CN Patent

CN114072153A — 用于治疗胆汁淤积的方法

Assigned to Mirum Pharmaceuticals Inc · Expires 2022-02-18 · 4y expired

What this patent protects

本文提供了用于治疗患有肝病的受试者的胆汁淤积的方法。所述方法包括向所述受试者施用顶端钠依赖性胆汁酸转运体(ASBTI)。更具体地，本发明涉及用于治疗受试者的胆汁淤积的方法，其中所述方法包括以至少10μg/kg/天的剂量向受试者施用ASBTI。

USPTO Abstract

本文提供了用于治疗患有肝病的受试者的胆汁淤积的方法。所述方法包括向所述受试者施用顶端钠依赖性胆汁酸转运体(ASBTI)。更具体地，本发明涉及用于治疗受试者的胆汁淤积的方法，其中所述方法包括以至少10μg/kg/天的剂量向受试者施用ASBTI。

Drugs covered by this patent

maralixibat-chloride (MARALIXIBAT CHLORIDE)

Patent Metadata

Patent number: CN114072153A
Jurisdiction: CN
Classification: —
Expires: 2022-02-18
Drug substance claim: No
Drug product claim: No
Assignee: Mirum Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.